Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
THC · against 1,216 other Healthcare companies
Ranked #567 of 1,217 · scores higher than 53% of peers
Bars: peers in each 10-point band of the growth score122 peers with a growth score of 50–59, including THC · Click a bar to see the companies
A mix: stronger earnings per share growth, but weaker 3-year revenue growth than most Healthcare peers.
| Metric | THC | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 1,243 reported | 5.4% | 6.1% | 48% | 33% | |
| Earnings per share growthHigher is better · 682 reported | 45.3% | 9.7% | 75% | 33% | |
| 3-year revenue growthHigher is better · 1,192 reported | 3.1% | 5.8% | 39% | 33% |
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 464M USD | 100 | 53 | |
| 3 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 3 | 1.8B HKD (≈$224M) | 99 | 59 | |
| 3 | 7.2B TWD (≈$224M) | 99 | 41 | |
| 567 | 51M EUR (≈$56M) | 53 | 22 | |
| 567 | 470M EUR (≈$517M) | 53 | 56 | |
| 567 | 3.6B GBP (≈$4.7B) | 53 | 64 | |
| 567 | 2.5B USD | 53 | 60 | |
| 567 | 21.5B USD | 53 | 60 | |
| 567 | 1.2B USD | 53 | 24 | |
| 567 | 25.8B USD | 53 | 75 | |
| 579 | 8.9B CNY (≈$1.2B) | 52 | 42 | |
| 579 | 80.2B CNY (≈$11.2B) | 52 | 76 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score